CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice - sprookjes - yvandenbroek - TriplyDB

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

http://www.wikidata.org/entity/Q33597242

about

Novel vaccine development strategies for inducing mucosal immunity Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Adjuvant activity of CpG oligodeoxynucleotides Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens Type I interferon is required to mount an adaptive response to immunostimulatory DNA Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen.Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist.Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant Coccidioidomycosis: host response and vaccine development MG7 mimotope-based DNA vaccination for gastric cancer.Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants.CpG Oligodeoxynucleotides Enhance the Activities of CD8+ Cytotoxic T-Lymphocytes Generated by Combined hMUC1 Vaccination and hNIS Radioiodine Gene Therapy.Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models Vaccination in the neonatal period and early infancy.DNA vaccination and the immune responsiveness of neonates.Neonatal immunity and somatic mutation.Construction and characterization of calreticulin-HBsAg fusion gene recombinant adenovirus expression vector.Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.An overview of cancer immunotherapy.Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.Rescue of B cells from apoptosis by immune stimulatory CpG DNA.Immunostimulatory DNA sequences and cancer therapy.The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.Unbalanced Neonatal CD4(+) T-Cell Immunity Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.Maternal vaccination: moving the science forward.CpG DNA as a vaccine adjuvant.Immune responses of female BALB/c and C57BL/6 neonatal mice to vaccination or intestinal infection are unaltered by exposure to breast milk lycopene Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120.Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703.Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.Use of CpG oligodeoxynucleotides as immune adjuvants.A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms

P2860

Q24607533-1BCA5EEA-57CD-47BE-8DED-F5AD3DE143D3 Q28187952-7708E207-5672-4890-BA92-6B2C41D77D5A Q28250104-6A115365-DC58-4DF3-A184-1B4D5F39419F Q28347424-99774D91-DDA2-4C9B-B6FE-B924D81E152F Q28508204-9818EDB0-53C0-43A8-8176-119884446F4A Q30373251-2A296656-A0A2-4B7B-BA27-D3208ABA7ABD Q30573156-5E0D76C3-00D6-4F1A-80EA-832547EF9AEF Q30853592-A51DC5E1-EF3D-45B1-B479-F997422CE0BE Q33207983-2341360D-87FE-4F4F-8A64-D2AE72C6A185 Q33239626-C801A04D-D44C-4331-97C4-91EE4FF948FE Q33597488-890FD070-0501-4238-978D-18D1E9DEAABE Q33704106-656B1F8C-FE68-4DB7-BCAC-43B0064E7694 Q33781642-ACE82832-5B62-4EA3-ABE5-D94F5BB47A63 Q33867634-8C42F4B3-ACDE-40D9-B2FC-BA4CEA6C150C Q33891058-7C058485-36F8-438E-9645-ABCFFD8A87FB Q33891065-55A3D55A-CDC5-4844-B909-FA6440D8E6F3 Q33891076-74A162DB-5350-4033-B1BA-10BECD49409F Q33935644-DBBBF436-0EE4-4197-8DA0-52F8B8EAD612 Q33936717-4976AAF8-8483-408D-950F-F475A38F58E8 Q33940388-F0C2977A-0FF9-4345-BC30-92828DAEC212 Q34002329-6DD4AEFD-2A63-4F85-A014-D10FC0AE5A88 Q34005396-0CEAA93E-7753-4480-A021-35F08602D93B Q34005429-B378FC05-DA82-40E7-B7FF-E7D2EAA948E3 Q34016039-AF0D0764-A9B8-4C6B-B8FA-856CE6698D01 Q34091987-2F6B9462-9153-40DE-8FB5-2430676CB919 Q34118325-B9EFFBBE-88B7-4340-B54A-76EA117A6A4D Q34238526-A208605B-8484-4C00-9EB8-0FD50BFB540C Q34289051-84AF4C15-2688-4E86-9EC6-72DC0C35DA8C Q34382810-269D0AF8-3B16-4BAC-ABC5-709787750EE7 Q34437852-AB42197A-3421-423A-8BF2-720FE92FBBB4 Q34630952-1C7219B9-AF23-4B2C-AC1D-A4942D98F2E0 Q35025722-06C69EE5-4F0D-4B89-A072-7FA4024FA883 Q35040045-3E145DBF-5350-4DA1-B40D-FA10414AA14D Q35111000-44578F1C-559F-45A2-A6BA-F21824B75358 Q35602700-FC594697-32CC-4098-AE8F-8467A1CB486E Q35623329-21845261-6916-4F36-A8B2-1EFC628A485F Q35635250-C50A8485-01CE-46EE-96E8-251FC2821397 Q35801755-69493A5E-07FC-4C9D-92AC-D6E628A60651 Q35826404-72EE84C1-E365-4C7F-99B2-D340F358911C Q35895400-03B6862D-4E85-4409-AE92-3099B8A7DE8A

P2860

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

http://www.wikidata.org/entity/Q33597242

description

1998 nî lūn-bûn

@nan

1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

CpG DNA can induce strong Th1 ...... surface antigen in young mice

@ast

CpG DNA can induce strong Th1 ...... surface antigen in young mice

@en

type

label

CpG DNA can induce strong Th1 ...... surface antigen in young mice

@ast

CpG DNA can induce strong Th1 ...... surface antigen in young mice

@en

prefLabel

CpG DNA can induce strong Th1 ...... surface antigen in young mice

@ast

CpG DNA can induce strong Th1 ...... surface antigen in young mice

@en

P1433

Q33597242-9F5B11AD-BE8B-4EBE-B0FE-90FA4C18D332

P1476

Q33597242-C10340A3-5FE1-4924-854A-816D9F85AAC4

P2093

Q33597242-06540D85-12B0-4AEF-B653-68C8E419617B

Q33597242-0D50A123-D852-4112-B945-7D96EE998393

Q33597242-1E9A9382-B623-4744-8C0D-BE9B52E8142C

Q33597242-356F3FAF-AAF6-4F22-9404-A7371A29E2D5

Q33597242-C0CFFF36-ED8D-43F9-8916-0768ADE57C0E

P2860

Q33597242-0122C566-51A9-42E5-ACB3-F4B38C3F411A

Q33597242-051BA4C1-CC8C-4EC5-85DB-EBDCDD3AB22D

Q33597242-0770CBA3-4C0A-4D84-BC45-A9A4BFC637A3

Q33597242-0D65663B-0F0F-49B9-807F-C3DE4316FDBC

Q33597242-18D48D12-34E3-46B2-8BB2-60542C117411

Q33597242-288981C4-4157-4E92-9C9E-8A2FC5E03BDA

Q33597242-2E623179-C263-402F-8C5F-5C6EC5BFDCAC

Q33597242-337CAE55-F459-4C3A-8E9E-856BD1BF297D

Q33597242-3528B9F7-9E3C-43AC-B9B2-E5868F90EBE4

Q33597242-36FBB126-608D-45EE-86A9-D5D8BBFC5592

P304

Q33597242-54959ADD-C0CC-4D7E-BAE4-F06AAA1449D1

P31

Q33597242-0AAFD58A-3D3E-4EE5-884D-E1C478407EA7

P356

Q33597242-52379F13-F804-47D5-B133-F4830F74DB71

P407

Q33597242-55894C08-23B3-4804-B20B-E0FFD8B4D2AD

P433

Q33597242-6DDF7060-B21B-4722-A7AD-2165837FC0C5

P478

Q33597242-B8D8E782-6914-428C-BA1B-93D1F1A4D5B3

P577

Q33597242-9737D68D-09A5-4949-9BE2-29DF186A77CA

P5875

Q33597242-5E0DF05E-AF0C-468A-8104-9CF274CC424E

P698

Q33597242-FEEBAFD5-FA16-4815-AFA4-AE9F0B3D70BC

P932

Q33597242-6BA4F74D-39A7-4BE1-B1C2-A0317C93C1BB

P356

PNAS.95.26.15553

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

CpG DNA can induce strong Th1 ...... surface antigen in young mice

@en

P2093

Brazolot Millan CL

http://www.w3.org/2001/XMLSchema#string

Davis HL

http://www.w3.org/2001/XMLSchema#string

Krieg AM

http://www.w3.org/2001/XMLSchema#string

Siegrist CA

http://www.w3.org/2001/XMLSchema#string

Weeratna R

http://www.w3.org/2001/XMLSchema#string

P2860

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.

CpG motifs in bacterial DNA trigger direct B-cell activation.

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.

Photolysis of the carbon monoxide complex of myoglobin: nanosecond time-resolved crystallography.

Contribution of CpG motifs to the immunogenicity of DNA vaccines.

Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge.

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

P304

15553-15558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.26.15553

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13426822

http://www.w3.org/2001/XMLSchema#string

P698

9861007

http://www.w3.org/2001/XMLSchema#string

P932

28081

http://www.w3.org/2001/XMLSchema#string